↓ Skip to main content

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and…

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, June 2001
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent
8 patents

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
8 Mendeley
Title
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
Published in
Cancer Chemotherapy and Pharmacology, June 2001
DOI 10.1007/s002800000270
Pubmed ID
Authors

Henning Bier, Thomas Hoffmann, Ulrich Hauser, Michael Wink, Martin Öchler, Andreas Kovar, Matthias Müser, Reinald Knecht

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 13%
Unknown 7 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 25%
Student > Doctoral Student 1 13%
Other 1 13%
Student > Bachelor 1 13%
Professor > Associate Professor 1 13%
Other 0 0%
Unknown 2 25%
Readers by discipline Count As %
Medicine and Dentistry 6 75%
Unknown 2 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2017.
All research outputs
#3,465,367
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#118
of 2,501 outputs
Outputs of similar age
#3,632
of 40,481 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#3
of 23 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 40,481 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.